Next |
home / stock / vir / vir message board
Subject | By | Source | When |
---|---|---|---|
48w VIR-2219 +peg-IFN>31% HBs seroconverion: | DewDiligence | investorshub | 11/06/2022 11:32:58 PM |
$VIR EASL presentations: | DewDiligence | investorshub | 06/25/2022 7:50:22 PM |
$VIR HBV webcast slides: | DewDiligence | investorshub | 04/27/2022 4:03:27 PM |
$VIR -14% on amended Sotrovimab EUA due to | DewDiligence | investorshub | 03/25/2022 8:28:36 PM |
$VIR 4Q21 results: | DewDiligence | investorshub | 02/24/2022 9:25:27 PM |
VIRs 2022 HBV newsflow: | DewDiligence | investorshub | 02/24/2022 9:23:46 PM |
Up so far on another Biotech down day | rwwest | investorshub | 01/21/2022 5:45:54 PM |
VIR slide set from $JPM: | DewDiligence | investorshub | 01/11/2022 6:45:08 PM |
VIR/$GILD start phase-2 trial testing quadruple regimen of | DewDiligence | investorshub | 12/09/2021 3:06:10 PM |
Loaded again. After omicron news all weekend this | HokieHead | investorshub | 12/03/2021 4:58:52 PM |
In $46, omicron play. | HokieHead | investorshub | 12/02/2021 8:19:15 PM |
$VIR starts HBV combination trial of $VIR-2218 and $VIR-3434: | DewDiligence | investorshub | 07/15/2021 4:34:13 PM |
VIR -6% on VIR-2218 and VIR-3434 monotherapy data | DewDiligence | investorshub | 06/25/2021 2:31:45 PM |
profound efficacy. Vir Biotechnology and $GSK plan to | level42 | investorshub | 03/11/2021 10:35:51 PM |
Too high too fast. Very typical price movement. | interloper | investorshub | 01/29/2021 6:44:43 PM |
why is $VIR coming back down??? | dealerschool2006 | investorshub | 01/28/2021 4:29:24 PM |
Huge disappointment. | rtrstock | investorshub | 01/27/2021 8:40:09 PM |
Two New Rockships Taking Off After$ VIR Behold!$ FNMA | CatBirdSeat | investorshub | 01/27/2021 5:12:58 PM |
I Should have sold at 140.00 | rtrstock | investorshub | 01/27/2021 4:58:34 PM |
Full of crap haha | Srhogan1984 | investorshub | 01/27/2021 2:55:41 AM |
News, Short Squeeze, Breakout and More Instantly...
Vir Biotechnology Inc. Company Name:
VIR Stock Symbol:
NYSE Market:
Vir Biotechnology, Inc. (“Vir” or “the Company”, Nasdaq: VIR) today announced the nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors (the “Board”) at its upcoming annual meeting of stockholders on May 29, 2024 (the ...
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a corporate update and report financial results for the first quarter ended March 31, 2024, on May 2, 2024. The Company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on May 2, 2024. ...
2024-03-26 14:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...